Status:
COMPLETED
A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly Volunteers
Lead Sponsor:
Pfizer
Conditions:
Healthy
Eligibility:
All Genders
70-80 years
Brief Summary
The purpose of the study is to evaluate the difference in learning and performance measures associated with repeated use of an iPad video game (Akili Interactive's Project: EVO) in healthy elderly vol...
Eligibility Criteria
Inclusion
- Healthy males and females between the ages of 70 and 80.
- Subjects must have BMI of 17.5 to 32 kg/m2 and total body weight \> 110 pounds.
- Acceptable screening MRI and PET scans that pass quality control requirements.
Exclusion
- Co-morbid diagnosis of clinically documented Alzheimer's disease; - Significant cognitive impairment;
- MMSE (mini mental state examination) score \<26
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT02265718
Start Date
September 1 2014
End Date
May 1 2016
Last Update
June 5 2019
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Collaborative Neuroscience Network, LLC
Long Beach, California, United States, 90806
2
Broward Research Group
Hollywood, Florida, United States, 33024
3
Miami Research Associates
South Miami, Florida, United States, 33143
4
Jasper Clinic, Inc.
Kalamazoo, Michigan, United States, 49007